APT(SH:688617) Sou Hu Cai Jing·2025-08-16 19:57Core Points - As of August 15, 2025, Huatai Medical (688617) closed at 297.42 CNY, up 3.17% from the previous week [1] - The company's market capitalization is currently 41.94 billion CNY, ranking 4th out of 126 in the medical device sector and 379th out of 5,152 in the A-share market [1] Company Announcements - Cheng Zhenghui plans to reduce his holdings by no more than 2,820,275 shares, which is up to 2% of the company's total share capital, through block trading [1] - Cheng Zhenghui holds 26,371,507 shares, representing 18.7014% of the total share capital, and together with his associate Wen Yiming, they hold 26,391,272 shares, accounting for 18.7154% [1] - The last reduction occurred on April 15, 2024, where 4,173,116 shares were sold at a price of 471.12 CNY per share, representing a reduction of 6.2414% [1] - Cheng Zhenghui committed not to transfer or delegate the management of his shares for 36 months from the date of listing and is limited to transferring no more than 25% of his holdings annually while serving as a director, supervisor, or senior management [1] - The reduction plan complies with relevant laws and regulations and will not significantly impact the company's governance structure or ongoing operations [1]